The U.S. Food and Drug Association is reviewing AbbieVie's New Drug Application (NDA) for a new treatment of Hepatitis C virus.  Read More »

The U.S. Food and Drug Administration has approved deflazacort, a new treatment for Duchenne muscular dystrophy in patients 5 years and older. Read More »

Global pharmaceutical leader Allergan is launch a new campaign to bring awareness to blindness, and commit to fighting preventable blindness in the United States in its new See America initiative. Read More »

Teva Pharmaceutical Industries' chairman Yitzhak Peterburg has been appointed interim president and chief executive officer. Read More »

McKesson Health Solutions, a company that specializes in helping patients with medical payments, recently announced its new analytics system HealthQx received certification in the Prometheus Analytics model. Read More »

The Lower Drug Costs through Competition Act created by the House Energy and Commerce Committee was taken off the committee’s fast track on Feb. 3 Read More »

Medical business management service provider Medac Inc. has completed a Service Organization Control 2 certification. Read More »

GSK Consumer Healthcare has launched Flonase Allergy Relief for the treatment of seasonal allergies. Read More »

Newly released data published in the Multiple Sclerosis Journal shows Cladribine tablets significantly reduce brain atrophy in patients suffering with multiple sclerosis. Read More »

Global pharmaceutical maker Mylan will host Investor Day on March 1 in New York City. Read More »

Biotech company Amgen submitted an application to the U.S. Food and Drug Administration for Blincyto, a drug used in the treatment of lymphoblastic leukemia, to broaden its uses and treatments. Read More »

The Missoula Urban Indian Health Center is participating in offering education, care coordination and patient-navigator services to more than 30 Indian tribes.  Read More »

The Department of Veterans Affairs is looking to expand pharmacists’ roles as health care providers for veterans living in rural communities.  Read More »

The Centers for Disease Control and Prevention has releases detailed information on the risks that flu season presents.  Read More »

Recently passed legislation now allows Medicare to pay pharmacists for services provided to beneficiaries in underserved communities. Read More »

The European Commission has granted Eli Lilly & Co. marketing rights for Olumiant, a drug used to treat patients suffering with severe rheumatoid arthritis. Read More »

Cumberland Pharmaceuticals Inc.'s recent clinical study showed its Caldolor Injection (ibuprofen) to be a safe and effective source of fever reduction in hospitalized pediatric use. Read More »

AbbVie, a global biopharmaceutical company focused on research, will take part in the upcoming Cowen and Company 37th Annual Health Care Conference.  Read More »

CBI's Formulary, Co-Pay and Access Summit will convene April 11-12 to address patient affordability barriers and more.  Read More »

GlaxoSmithKline was awarded damages, fees and interest on Jan. 31 as arbitration concluded with Pernix Therapeutics Holdings Inc.  Read More »